Advertisement

Journal of Cancer Survivorship

, Volume 8, Issue 3, pp 410–418 | Cite as

Weight gain prior to entry into a weight-loss intervention study among overweight and obese breast cancer survivors

  • Rebecca L. SedjoEmail author
  • Tim Byers
  • Patricia A. Ganz
  • Graham A. Colditz
  • Wendy Demark-Wahnefried
  • Kathleen Y. Wolin
  • Maria Azrad
  • Cheryl L. Rock
Article

Abstract

Purpose

Changes in cancer therapy, in addition to changes in obesity prevalence, suggest the need for a current assessment of weight gain patterns following breast cancer diagnosis. The aim of this study was to evaluate factors associated with weight gain among breast cancer survivors prior to enrolling into a behavioral weight loss intervention.

Methods

Anthropometric measures and data on weight-related factors were collected at baseline on 665 breast cancer survivors. Postdiagnosis weight gain was determined between entry into the trial and previous diagnosis up to 5 years. Multivariate logistic regression analyses were used to evaluate the association between weight gain and influencing factors.

Results

The mean weight gain was 4.5 % body weight (standard deviation = 10.6); 44 % of women experienced ≥5 % body weight gain. The risk of weight gain was inversely associated with age (adjusted odds ratio (ORadj) = 0.97, 95 % confidence interval (95 % CI) 0.95–0.99), Hispanic ethnicity (ORadj = 0.30, 95 % CI 0.13–0.68), and overweight (ORadj = 0.11, 95 % CI 0.05–0.23) or obese (ORadj = 0.03, 95 % CI 0.02–0.07) status at diagnosis and positively associated with time elapsed since diagnosis (ORadj = 1.19/year, 95 % CI 1.04–1.36). Women prescribed aromatase inhibitors were 46 % less likely to gain weight compared to women prescribed selective estrogen-receptor modulators (ORadj = 0.54, 95 % CI 0.31–0.93). The risk of weight gain was positively associated with smoking at diagnosis (ORadj = 2.69, 95 % CI 1.12–6.49) although this was attributable to women who subsequently quit smoking.

Conclusions

Postdiagnosis weight gain is common and complex and influenced by age, ethnicity, weight, smoking status, time elapsed since diagnosis, and endocrine-modulating therapy.

Implications for cancer survivors

Weight gain continues to be a concern following a diagnosis of breast cancer. Factors influencing this weight gain include age, ethnicity, weight, smoking status, time elapsed since diagnosis, and endocrine-modulating therapy. Effective weight management strategies are needed for this population of women.

Keywords

Breast cancer survivors Weight gain Women 

Notes

Acknowledgments

Funding for the ENERGY trial was provided by the National Cancer Institute (CA148791). This research was also supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) under award number UL1TR00165 at the University of Alabama at Birmingham and by the NIH/NCATS Colorado CTSI Grant Number UL1 TR001082 at the University of Colorado Denver. Contents are the authors’ sole responsibility and do not necessarily represent official NIH views. The authors would also like to recognize the subjects for their participation and to acknowledge the ENERGY Trial Group.

The ENERGY trial group

University of California, San Diego: Cheryl Rock, PhD, RD, Bilge Pakiz, EdD, Barbara Parker, MD, Chris Zoumas, MS, RD, Shirley Flatt, MS, Hava Shoshana Barkai, MS, RD, Dennis Heath, MS, Lea Jacinto, Mila Pruitt.

University of California, Los Angeles: Patricia A. Ganz, MD.

University of Colorado Denver: Tim Byers, MD, MPH, Rebecca Sedjo, PhD, Holly Wyatt, MD, Anthony Elias, MD, Anna Van Pelt, MPH, Kim Gorman, MS, RD.

Washington University in St. Louis: Graham Colditz, MD, Kathleen Wolin, ScD, Esther Liu, PhD, Michael Naughton, MD, Casey Fagin, MA, Jennifer Tappenden, Sonya Izadi.

University of Alabama at Birmingham: Wendy Demark-Wahnefried, PhD, RD, Helen Krontiras, MD, Maria Azrad, PhD, RD, Cindy Blair, PhD, Sonthe Burge, MS, RD.

Conflict of interest

The authors (RLS, TB, PG, GC, WDW, KYW, MA, CLR) declare no disclosures of any financial or personal relationships that could pose a conflict of interest with the subject matter of this article.

References

  1. 1.
    Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2010;123:627–35.CrossRefPubMedGoogle Scholar
  2. 2.
    Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol. 2005;23:1370–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Caan BJ, Emond JA, Natarajan L, Castillo A, Gunderson EP, Habel L, et al. Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat. 2006;99:47–57.CrossRefPubMedGoogle Scholar
  4. 4.
    Caan BJ, Kwan ML, Hartzell G, Castillo A, Slattery ML, Sternfeld B, et al. Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control. 2008;19:1319–28.PubMedCentralCrossRefPubMedGoogle Scholar
  5. 5.
    Nichols HB, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Holmes MD, Bersch AJ, et al. Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomarkers Prev. 2009;18:1403–9.PubMedCentralCrossRefPubMedGoogle Scholar
  6. 6.
    Caan BJ, Kwan ML, Shu XO, Pierce JP, Patterson RE, Nechuta SJ, et al. Weight change and survival after breast cancer in the After Breast Cancer Pooling Project. Cancer Epidemiol Biomarkers Prev. 2012;21:1260–71.PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Su HI, Sammel MD, Springer E, Freeman EW, DeMichele A, Mao JJ. Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors. Breast Cancer Res Treat. 2010;124:205–11.PubMedCentralCrossRefPubMedGoogle Scholar
  8. 8.
    Caan BJ, Emond JA, Su HI, Patterson RE, Flatt SW, Gold EB, et al. Effect of postdiagnosis weight change on hot flash status among early-stage breast cancer survivors. J Clin Oncol. 2012;30:1492–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Forsythe LP, Alfano CM, George SM, McTiernan A, Baumgartner KB, Bernstein L, et al. Pain in long-term breast cancer survivors: the role of body mass index, physical activity, and sedentary behavior. Breast Cancer Res Treat. 2013;137:617–30.PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Imayama I, Alfano CM, Neuhouser ML, George SM, Wilder Smith A, Baumgartner RN, et al. Weight, inflammation, cancer-related symptoms and health-related quality of life among breast cancer survivors. Breast Cancer Res Treat. 2013;140:159–76.PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569–78.CrossRefPubMedGoogle Scholar
  12. 12.
    Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2010. JAMA. 2010;303:235–41.CrossRefPubMedGoogle Scholar
  13. 13.
    Vance V, Mourtzakis M, McCargar L, Hanning R. Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obes Rev. 2011;12:282–94.CrossRefPubMedGoogle Scholar
  14. 14.
    Demark-Wahnefried W, Rimer BK, Winer EP. Weight gain in women diagnosis with breast cancer. J Am Diet Assoc. 1997;97:519–29.CrossRefPubMedGoogle Scholar
  15. 15.
    Rock CL, Flatt SW, Newman V, Caan BJ, Haan MN, Stefanick ML, et al. Factors associated with weight gain in women after diagnosis of breast cancer. J Am Diet Assoc. 1999;99:1212–21.CrossRefPubMedGoogle Scholar
  16. 16.
    Goodwin P, Ennis M, Pritchard K, McCready D, Koo J, Sidlofsky S, et al. Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol. 1999;17:120–9.PubMedGoogle Scholar
  17. 17.
    Rock CL, Byers TE, Colditz GA, Demark-Wahnefried W, Ganz P, Wolin KY, et al. Reducing breast cancer recurrence with weight loss, a vanguard trial: the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial. Contemp Clin Trials. 2013;34:282–95.PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Klein S, Burke LE, Bray GA, Blair S, Allison DB, Pi-Sunyer X, et al. Clinical implications of obesity with specific focus on cardiovascular disease. A statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2004;110:2952–67.CrossRefPubMedGoogle Scholar
  19. 19.
    Doyle C, Kushi LH, Byers T, Courneya KS, Demark-Wahnefried W, Grant B, et al. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin. 2006;56:323–53.CrossRefPubMedGoogle Scholar
  20. 20.
    American Diabetes Association Task Force for Writing Nutrition Principles and Recommendations for the management of diabetes: American Diabetes Association position statement: evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. J Am Diet Assoc. 2002;102;109–18.Google Scholar
  21. 21.
    Saquib N, Flatt SW, Natarajan L, Thomson CA, Bardwell WA, Caan B, et al. Weight gain and recovery of pre-cancer weight after breast cancer treatments: evidence from the women’s healthy eating and living (WHEL) study. Breast Cancer Res Treat. 2007;105:177–86.CrossRefPubMedGoogle Scholar
  22. 22.
    Sedjo RL, Hines LM, Byers T, Giuliano AR, Marcus A, Vadaparampil S, et al. Long-term weight gain among Hispanic and non-Hispanic White women with and without breast cancer. Nutr Cancer. 2013;65:34–42.CrossRefPubMedGoogle Scholar
  23. 23.
    Travier N, Agudo A, May AM, Gonzalez C, Luan J, Wareham NJ, et al. Longitudinal changes in weight in relation to smoking cessation in participants of the EPIC-PANACEA study. Prev Med. 2012;54:183–92.CrossRefPubMedGoogle Scholar
  24. 24.
    Williamson DF, Madans J, Anda RF, Kleinman JC, Giovino GA, Byers T. Smoking cessation and severity of weight gain in a national cohort. NEJM. 1991;324:739–45.CrossRefPubMedGoogle Scholar
  25. 25.
    Basterra-Cortari FJ, Forga L, Bes-Rastrollo M, Toledo E, Martinez JA, Martinex-Gonzalez MA. Effects of smoking on body weight: longitudinal analysis of the SUN cohort. Rev Esp Cardiol. 2010;63:20–7.CrossRefGoogle Scholar
  26. 26.
    Luo J, Rossouw J, Margolis KL. Smoking cessation, weight change, and coronary heart disease among postmenopausal women with and without diabetes. JAMA. 2013;310(1):94–6. doi: 10.1001/jama.2013.6871.CrossRefPubMedGoogle Scholar
  27. 27.
    Gu K, Chen X, Zhen Y, Chen Z, Zheng W, Lu W, et al. Weight change patterns among breast cancer survivors: results from the Shanghai breast cancer survival study. Cancer Causes Control. 2010;21(4):621–9.PubMedCentralCrossRefPubMedGoogle Scholar
  28. 28.
    Han HS, Lee KW, Kim JH, Kim SW, Kim IA, Oh DY, et al. Weight changes after adjuvant treatment in Korean women with early breast cancer. Breast Cancer Res Treat. 2009;114:147–53.CrossRefPubMedGoogle Scholar
  29. 29.
    Chen X, Lu W, Gu K, Chen Z, Zheng Y, Zheng W, et al. Weight change and its correlates among breast cancer survivors. Nutr Cancer. 2011;63:538–48.PubMedCentralCrossRefPubMedGoogle Scholar
  30. 30.
    Yaw WH, Shariff ZM, Kaniah M, Mun CY, Yusof RM, Othman Z, et al. Weight changes and lifestyle behaviors in women after breast cancer diagnosis: a cross-sectional study. BMC Public Health. 2011;11:309–18.PubMedCentralCrossRefPubMedGoogle Scholar
  31. 31.
    Trédan O, Bajard A, Meunier A, Roux P, Fiorletta I, Gargi T, et al. Body weight change in women receiving adjuvant chemotherapy for breast cancer: a French prospective study. Clin Nutr. 2010;29:187–91.CrossRefPubMedGoogle Scholar
  32. 32.
    Reddy S, Sadim M, Li J, Yi N, Agarwal S, Mantzoroas CS, et al. Clinical and genetic predictors of weight gain in patients diagnosed with breast cancer. Br J Cancer. 2013;109:872–81.PubMedCentralCrossRefPubMedGoogle Scholar
  33. 33.
    Wing RR. Obesity and weight gain during adulthood: a health problem for United States women. WHI. 1992;2:114–22.PubMedGoogle Scholar
  34. 34.
    Colditz GA, Willett WC, Stampfer MJ, London SJ, Segal MR, Speizer FE. Patterns of weight change and their relations to diet in a cohort of healthy women. Am J Clin Nutr. 1990;51:1100–5.PubMedGoogle Scholar
  35. 35.
    Brown WJ, Williams L, Ford JH, Ball K, Dobson AJ. Identifying the energy gap: magnitude and determinants of 5-year weigh gain in midage women. Obes Res. 2005;13:1431–44.CrossRefPubMedGoogle Scholar
  36. 36.
    Irwin ML, McTiernan A, Baumgartener R, Bumgartener KB, Bernstein L, Gilliland FD, et al. Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognastic, and lifestyle factors. J Clin Oncol. 2005;23:774–82.PubMedCentralCrossRefPubMedGoogle Scholar
  37. 37.
    Theriault RL, Carlson RW, Anderson BO, Burstein HJ, Edge SB, Farrar WB, et al. Breast cancer. National Comprehensive Cancer Network Guidelines, version 3.2013. http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf (Accessed: 10/23/2013)
  38. 38.
    Filozof C, Pinilla CF, Fernández-Cruz A. Smoking cessation and weight gain. Obes Rev. 2004;5:95–103.CrossRefPubMedGoogle Scholar
  39. 39.
    Makari-Judson G, Judson CH, Mertens WC. Longitudinal patterns of weight gain after breast cancer diagnosis: observations beyond the first year. Breast J. 2007;13(3):258–65.CrossRefPubMedGoogle Scholar
  40. 40.
    Heideman WH, Russell NS, Gundy C, Rookus MA, Voskuil DW. The frequency, magnitude and timing of post-diagnosis body weight gain in Dutch breast cancer survivors. Eur J Cancer. 2009;45:119–26.CrossRefPubMedGoogle Scholar
  41. 41.
    Freedman RJ, Aziz N, Albanes D, Hartman T, Danforth D, Hill S, et al. Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer. J Clin Endocrinol Metab. 2004;89:2248–53.CrossRefPubMedGoogle Scholar
  42. 42.
    The ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists’ Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet. 2002;359:2131–9.CrossRefGoogle Scholar
  43. 43.
    Francini G, Petrioli R, Montagnani A, Cadirni A, Campagna S, Francini E, et al. Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids. Br J Cancer. 2006;95:153–8.PubMedCentralCrossRefPubMedGoogle Scholar
  44. 44.
    Petrek JA, Naughton MJ, Case LD, Paskett ED, Naftalis EZ, Singletary SE, et al. Incidence, time course, and determinates of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol. 2006;24:1045–51.CrossRefPubMedGoogle Scholar
  45. 45.
    Partridge A, Gelber S, Gelber RD, Castiglione-Gertsch M, Goldhirsch A, Winer E. Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI. Eur J Cancer. 2007;43:1646–53.CrossRefPubMedGoogle Scholar
  46. 46.
    Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–41.CrossRefPubMedGoogle Scholar
  47. 47.
    Lin CJ, Deroo LA, Jacobs SR, Sandler DP. Accuracy and reliability of self-reported weight and height in the Sister Study. Public Health Nutr. 2011;9:1–11.Google Scholar
  48. 48.
    Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88–108. doi: 10.1186/1471-2458-9-88.PubMedCentralCrossRefPubMedGoogle Scholar
  49. 49.
    Pi-Sunyer X. The medical risks of obesity. Postgrad Med. 2009;121:21–33.PubMedCentralCrossRefPubMedGoogle Scholar
  50. 50.
    World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington DC: AICR; 2007.Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Rebecca L. Sedjo
    • 1
    Email author
  • Tim Byers
    • 2
  • Patricia A. Ganz
    • 3
  • Graham A. Colditz
    • 4
  • Wendy Demark-Wahnefried
    • 5
  • Kathleen Y. Wolin
    • 6
  • Maria Azrad
    • 7
  • Cheryl L. Rock
    • 8
  1. 1.Department of Community and Behavioral Health, Colorado School of Public HealthUniversity of Colorado DenverAuroraUSA
  2. 2.Department of Epidemiology, Colorado School of Public HealthUniversity of Colorado DenverAuroraUSA
  3. 3.Jonsson Comprehensive Cancer CenterUniversity of CaliforniaLos AngelesUSA
  4. 4.Washington University School of MedicineSaint LouisUSA
  5. 5.University of Alabama Comprehensive Cancer CenterUniversity of Alabama at BirminghamBirminghamUSA
  6. 6.Department of Public Health SciencesLoyola University Chicago Stritch School of MedicineMaywoodUSA
  7. 7.Department of Nutrition SciencesUniversity of Alabama at BirminghamBirminghamUSA
  8. 8.Department of Family and Preventive Medicine, School of MedicineUniversity of California San DiegoLa JollaUSA

Personalised recommendations